Cytek Biosciences, Inc. (CTKB)
NASDAQ: CTKB · Real-Time Price · USD
3.295
+0.075 (2.33%)
At close: Jun 16, 2025, 4:00 PM
3.300
+0.005 (0.15%)
After-hours: Jun 16, 2025, 4:00 PM EDT
Cytek Biosciences Employees
Cytek Biosciences had 648 employees as of December 31, 2024. The number of employees decreased by 28 or -4.14% compared to the previous year.
Employees
648
Change (1Y)
-28
Growth (1Y)
-4.14%
Revenue / Employee
$304,090
Profits / Employee
-$17,366
Market Cap
417.34M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 648 | -28 | -4.14% |
| Dec 31, 2023 | 676 | 93 | 15.95% |
| Dec 31, 2022 | 583 | 81 | 16.14% |
| Dec 31, 2021 | 502 | 111 | 28.39% |
| Dec 31, 2020 | 391 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
CTKB News
- 17 days ago - Cytek® Biosciences Is Setting the New Standard for Full Spectrum Flow Cytometry with the New Cytek Aurora™ Evo Flow Cytometer - GlobeNewsWire
- 19 days ago - Cytek Biosciences to participate at the Goldman Sachs 46th Annual Global Healthcare Conference - GlobeNewsWire
- 5 weeks ago - Cytek Biosciences, Inc. (CTKB) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Cytek Biosciences Reports First Quarter 2025 Financial Results - GlobeNewsWire
- 6 weeks ago - Cytek Biosciences: With Growth, Low Debt, And A Positive Long-Term Outlook, Is It Undervalued? - Seeking Alpha
- 6 weeks ago - Cytek® Biosciences Brings Cutting-Edge Cell Analysis Solutions to CYTO and IMMUNOLOGY2025 - GlobeNewsWire
- 7 weeks ago - Why Cytek Biosciences Should Beat Q1 Earnings Expectations - Seeking Alpha
- 7 weeks ago - Cytek Biosciences to Report First Quarter 2025 Financial Results on May 8, 2025 - GlobeNewsWire